Ohio Hepatitis Academic Mentorship Program

Tuesday, July 19, 2022, 7:30 AM - 5:30 PM


AMA PRA Category 1 Credits™ (8.00 hours), Non-Physician Attendance (8.00 hours), General Attendance (8.00 hours)

The Ohio Hepatitis Academic Mentorship Program (OH-HAMP) is designed to train primary care providers throughout the state using an in-person and telementoring-based approach. OH-HAMP’s goal is to improve the health of individuals in underserved communities by building a primary care workforce trained by experts to screen, diagnose, treat, cure and follow persons with chronic hepatitis C. OH-HAMP primary care providers will receive training on hepatitis C epidemiology, diagnosis, management, curative treatment, follow-up and prevention from disease experts. Thus, primary care providers throughout the state will be equipped with the skills needed to treat patients with hepatitis C in their local communities. This will increase the number of individuals who are identified and cured and help to reduce the number of Ohioans who can transmit hepatitis C to another person. OH-HAMP is a free, easily accessible training program that will be available to providers across the state. It will meet the needs of both primary care providers interested in providing hepatitis C care and current Ohio Medicaid and private payor requirements. OH-HAMP is designed to build (educate and empower) a mentorship platform that is accessible to primary care providers caring for high risk individuals in every part of Ohio, especially in rural, low resource settings.

1. Demonstrate knowledge of hepatitis C epidemiology, screening, diagnosis, management, curative treatment, follow-up and prevention.
2. Describe strategies to identify persons with hepatitis C infection.
3. Describe the increase of hepatitis C infection related to the injection drug epidemic in Ohio.
4. Show how to counsel patients about transmission risks.
5. Demonstrate understanding of the latest treatment options for hepatitis C infection
6. Identify testing procedures for perinatal transmission of hepatitis C: screening, testing, and treatment of infants born to mothers with chronic hepatitis C infection.
7. Describe the infrastructure necessary to support hepatitis care and treatment in primary care settings.
8. Demonstrate understanding of the recent and evolving changes to Ohio’s Medicaid program and how these changes impact hepatitis C treatment in the state.

The University of Toledo designates this activity for a maximum of 8.00 AMA PRA Category 1 Credit(s)^TM .  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Cancellation Policy

Cancellations received in writing no less than 20 days before the course will be refunded, less a 20% administrative fee. No refunds will be made on cancellations received after that date. Please send cancellation requests to University of [email protected]

University of Toledo Healthcare System reserves the right to cancel or postpone this program if necessary; in the event of cancellation, course fees will be fully refunded. We are not responsible for other costs incurred such as non-refundable airline tickets or hotel penalties.

Accessibility Statement
 
University of Toledo Healthcare System is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, including dietary concerns, please contact the CME Conference Coordinator.

The University of Toledo Healthcare System School of Medicine adheres to ACCME Criteria, Standards and Policies regarding industry support of continuing medical education. Disclosure of faculty and their commercial relationships will be made prior to the activity.

Mitigation of Relevant Financial Relationships

University of Toledo Continuing Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Tuesday, July 19, 2022

AbbVie and Gilead